Leidos : ranks on Military Times’ Best for Vets Employer List for sixth year in a row
May 14, 2019 at 04:43 am EDT
Share
(Reston, Va.) May 13, 2019 - Leidos (NYSE:LDOS), a FORTUNE® 500 science and technology leader, was named to the 2019 Military Times' Best for Vets Employer List. This marks the company's sixth consecutive year making this list, honoring its continuous dedication to hiring and supporting our nation's military veterans and their families.
The Best for Vets Employer List is a distinguished catalogue of the nation's top employers, selected and ranked through a months-long thorough application and vetting process. This year, Military Times received a record breaking number of applicants, with nearly 200 companies submitting for a spot on the list. Leidos ranked at #16 out of 113 companies, the highest ranking the company has received on this list to date.
"One of our key business advantages is that one in four of our 32,000 employees at Leidos are military veterans, and we work hard and dutifully to recruit and continually nurture these talented employees in our company," said Paul Engola, Leidos Chief Human Resources Officer & Head of Business Partnerships. "This high and consistent ranking honors the company's ongoing commitment to our veterans and their families, which remains at the helm of our company's driving mission and values."
Leidos works to recruit military veterans through Operation MVP, its military veteran program. This company-wide initiative is dedicated to finding, hiring, and supporting transitioning military veterans and their families. Currently, Leidos has over 7,000 veterans employed across the world.
The Military Times' Best for Vets Employer List works to objectively and particularly rank the nation's top companies in terms of their support, recruitment, and care for military veterans, service members, and their families. Transitioning service members look to this prestigious list for top companies to apply to, and as such, this list is an honorable recognition and recruitment tool for companies nationwide. For a full list of all ranked companies, visit https://charts.militarytimes.com/chart/13.
About Leidos
Leidos is a Fortune 500® information technology, engineering, and science solutions and services leader working to solve the world's toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The company's 32,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately $10.19 billion for the fiscal year ended December 28, 2018. For more information, visit www.Leidos.com.
Attachments
Original document
Permalink
Disclaimer
Leidos Holdings Inc. published this content on 13 May 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 14 May 2019 08:42:03 UTC
Leidos Holdings, Inc. specializes in the provision of engineering, technological and scientific services. Net sales by business segment break down as follows:
- defense (56.6%): design, engineering and integration of technological solutions for intelligence, airborne surveillance and reconnaissance, maritime and land-based solutions, electronic warfare systems, and automated sensor, alarm, command and control systems, software development, cyber security solutions and data processing and analysis solutions, IT infrastructure development and integration, etc.;
- civil security (23.7%): development and integration of solutions for the protection of goods, data and digital information, solutions and systems for air traffic flow control and flight data management, vehicle and cargo inspection, explosives and radiation detection, computer security, environmental management, nuclear security, complex logistics management, etc.;
- health (19.7%): integration of complex systems and technological infrastructures for the management of data, medical information and electronic health records, provision of healthcare services, IT systems lifecycle management, research and development of biopharmaceuticals, etc.
Net sales by market are divided between the US Department of Defense and the intelligence community (49.4%), government agencies (37.4%) and commercial customers (13.2%).
The United States accounts for 91,4% of net sales.